Evidence map›Paper›PMID 22921593›Full record

ArticleThe Journal of pediatrics2013

Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes.

Brian J Specht, R Paul Wadwa, Janet K Snell-Bergeon, Kristen J Nadeau, Franziska K Bishop, David M Maahs

Abstract read
In one paragraph

Article in The Journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2019
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Muscle mitochondrial function is impaired in adults with type 1 diabetes.Journal of diabetes and its complications · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Lipid management for cardiovascular risk reduction in type 1 diabetes.Current opinion in endocrinology, diabetes, and obesity · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brian J SpechtUniversity of Colorado School of Medicine, Aurora, CO 80045, USA.
R Paul Wadwa
Janet K Snell-Bergeon
Kristen J Nadeau
Franziska K Bishop
David M Maahs
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Training Program in Diabetes ResearchT32DK063687 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Andrea Steck · 2002 to 2026
$5.2M
Complications and Comorbidities of Type 1 DiabetesR01HL113029 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SNELL-BERGEON, JANET KATHLEEN · 2013 to 2016
$2.9M
Cardiovascular disease in Type 1 melitus: Young adults to adolescentsK23DK075360 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MAAHS, DAVID MATTHEW · 2007 to 2011
$663k
Insulin Control of Fat Regulation and Exercise in TeensK23RR020038 · NCRR · UNIVERSITY OF COLORADO DENVER · PI NADEAU, KRISTEN JANE · 2004 to 2008
$657k
Insulin Resistance In Adolescents With Diabetes: A New Frontier For CardiovasculaR56DK088971 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI NADEAU, KRISTEN JANE · 2010 to 2010
$215k
NCRR NIH HHS K23 RR020038NCRR NIH HHS UL1 RR025780NHLBI NIH HHS R01 HL113029NIDDK NIH HHS 1R56DK088971NIDDK NIH HHS 3-T32DK063687-07S1NIDDK NIH HHS DK075360NIDDK NIH HHS K23 DK075360NIDDK NIH HHS R56 DK088971NIDDK NIH HHS T32 DK063687
6 · The paper itself

Abstract

objectiveTo test the hypothesis that cardiovascular disease (CVD) risk factors are similar in nondiabetic (non-DM) adolescents compared with those with type 1 diabetes (T1D) in the most insulin-sensitive (IS) tertile, and that CVD risk factors are more atherogenic with decreasing IS in adolescents with T1D. STUDY

designIS for adolescents with T1D (n = 292; age = 15.4 ± 2.1 years; duration = 8.8 ± 3.0 years, hemoglobin A1c = 8.9% ± 1.6%) and non-DM controls (n = 89; age = 15.4 ± 2.1 years) was estimated using the model: log(e)IS = .64725 - 0.02032 (waist [cm]) - 0.09779 (hemoglobin A1c [%]) - 0.00235 (triglycerides [mg/dL]). CVD risk factors (blood pressure, fasting total and low- and high-density lipoprotein-cholesterol (HDL-c), high sensitivity C-reactive protein, and body mass index z score) were compared between all non-DM adolescents and those with T1D in the most IS tertile, and then examined for a linear trend by IS tertile in adolescents with T1D, adjusted for sex, race/ethnicity, and Tanner stage.

resultsEstimated IS was significantly lower in adolescents with T1D compared with those without (T1D = 7.8 ± 2.4, non-DM = 11.5 ± 2.9; P < .0001). CVD risk factors were similar for non-DM compared with the adolescents with T1D with the most IS, except for higher (HDL-c) and diastolic blood pressure in adolescents with T1D (P < .05). Among adolescents with T1D, all CVD risk factors except for (HDL-c), were more atherogenic across decreasing IS tertiles in linear regression analysis (P < .05).

conclusionAdolescents with T1D who are the most IS have similar CVD risk factors compared with non-DM adolescents. CVD risk factors are inversely associated with IS in adolescents with T1D. IS may be an important therapeutic target for reducing CVD risk factors in adolescents with T1D.

Indexed as

Insulin ResistanceAdolescentCardiovascular DiseasesDiabetes Mellitus, Type 1FemaleHumansMaleRisk Factors

Identifiers

PMID22921593
PMCPMC3509245
OpenAlexW2001018972

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.